Clinical trials: Eosinophilic Fasciitis
Eosinophilic Fasciitis
High-Intensity Laser Therapy for Eosinophilic Fasciitis
Eosinophilic fasciitis (EF) is a rare musculoskeletal disorder characterized by inflammation and thickening of the fascia, leading to pain, stiffness, and functional impairment.
- Trial name
- NCT05915585
- Testing
- High-Intensity Laser Therapy
- Where
- Egypt
- Volunteers
- 1 people
- Sponsor
- Ahram Canadian University
Scleroderma, Systemic, Graft Vs Host Disease
The Influence of Extracorporeal Photopheresis on Skin Sclerosis
Extracorporeal photopheresis (ECP), also known as extracorporeal photoimmunotherapy or photochemotherapy, is a leukapheresis-based therapy that has been in clinical use for over three decades after receiving FDA approval in 1988.
- Conditions
- Scleroderma, Systemic, Graft Vs Host Disease, Eosinophilic Fasciitis, Morphea
- Trial name
- NCT04752397
- Where
- Germany
- Volunteers
- 6 people
- Sponsor
- Charite University, Berlin, Germany
Eosinophilic Fasciitis
EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
Eosinophilic fasciitis is a connective tissue disorder characterized by inflammation of the muscle fasciae, which is very rare in children.
- Trial name
- NCT07348263
- Where
- 15 sites in United States, Croatia and 9 more
- Volunteers
- 20 people
- Sponsor
- Meyer Children's Hospital IRCCS
Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
This study will evaluate the safety and efficacy of the combination of rituximab and methotrexate to treat disabling fibrosing skin disorders.Rituximab will be administered at baseline and month 6.
- Trial name
- NCT00936546
- Testing
- Rituximab
- Where
- Belgium
- Volunteers
- 3 people
- Sponsor
- University Hospital, Ghent
Eosinophilic Fasciitis
Mepolizumab for Eosinophilic Fasciitis
This is a proof of concept pilot study to investigate the efficacy of mepolizumab in the treatment of eosinophilic fasciitis.
- Trial name
- NCT04305678
- Testing
- Mepolizumab
- Sponsor
- Mayo Clinic
Fasciitis
Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis
Evaluate the effect of high dose MTX on skin induration in patients with eosinophilic fascia.
- Trial name
- NCT00441961
- Testing
- methotrexate
- Where
- Netherlands
- Volunteers
- 6 people
- Sponsor
- Radboud University Medical Center
Shulman Fasciitis
Shulman Fasciitis Prevalence Study in Alsace
Shulman fasciitis or eosinophilic fasciitis (EF) is a rare inflammatory disease, usually benign but disabling, described by Shulman in 1974.
- Trial name
- SHULMAN (NCT02829112)
- Where
- France
- Volunteers
- 30 people
- Sponsor
- University Hospital, Strasbourg, France